← Evidence map

TrialMedical oncology (Northwood, London, England)2012

The early addition of arsenic trioxide versus high-dose arabinoside is more effective and safe as consolidation chemotherapy for risk-tailored patients with acute promyelocytic leukemia: multicenter experience.

Bin-Tao Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2012
2013
2014
2015
2016
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22038728